Scheduled presentations:

• In-silico trials for bone-implant systems: challenges, influencing parameters and clinical application
  M. Roland*, S. Diebels, A. Andres, K. Wickert, J. Stoeckl, S. Herrmann, T. Histing, B. Braun
• A methodological overview over genetically-based NTCP models for late toxicity after prostate cancer RT
  F. IEVA*, C. WEST, M. MASSI, N. FRANCO, A. PAGANONI, A. MANZONI, P. ZUNINO, T. RANCATI, A. DUNNING, P. SEIBOLD, A. WEBB, J. CHANG-CLAUDE
• Improving the Success Rate for Thoracic Radiotherapy through Specific Cardiac Substructure Dosimetry: Location Matters.
  A. Cicchetti*, A. Cavallo, S. Meroni, A. Allajbej, C. Sangalli, P. Vallerio
• Genetically-based analysis of bladder dose surface maps to identify subregions associated with late toxicities after prostate cancer radiotherapy
  E. Gioscio*, R. Consortium, M. Massi, N. Franco, F. Ieva, A. Cicchetti, P. Zunino, A. Paganoni, A. Manzoni, C. West, J. Chang-Claude, P. Seibold, T. Rancati, R. Consortium
• An Innovative Technical Rehabilitation Solution for Patients with Immobility Syndrome: The Pre-Clinical Results
  R. Bernardes, V. Parola, R. Cardoso, H. Neves, A. Cruz, W. Xavier, R. Durães, C. Malça*